Successful Use of TPO-Receptor Agonist Eltrombopag to Correct Thrombocytopenia for Unrelated-Donor Renal Transplant in an Adolescent with MYH-9-Related Disease
Pediatr Blood Cancer
.
2025 Jan 5:e31534.
doi: 10.1002/pbc.31534.
Online ahead of print.
Authors
Jillian Carter
1
,
Thunnisa Shanmugalingam
2
3
,
Sarah Lafond
2
,
Brendan Sudbury
2
,
Ben Hedley
4
,
Maha Saleh
1
5
,
Alp Sener
6
,
Joanne Grimmer
1
7
,
Soumitra Tole
1
8
Affiliations
1
Department of Pediatrics, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
2
Children's Hospital, London Health Sciences Centre, London, Ontario, Canada.
3
Arthur Labatt Family School of Nursing, Western University, London, Ontario, Canada.
4
Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
5
Medical Genetics Program of Southwestern Ontario, London Health Sciences Centre, London, Ontario, Canada.
6
Department of Surgery, Division of Urology, London Health Sciences Centre, London, Ontario, Canada.
7
Department of Pediatrics, Division of Nephrology, London Health Sciences Centre, London, Ontario, Canada.
8
Department of Pediatrics, Division of Hematology/Oncology, London Health Sciences Centre, London, Ontario, Canada.
PMID:
39757540
DOI:
10.1002/pbc.31534
No abstract available
Keywords:
MYH‐9; eltrombopag; transplant.
Publication types
Letter